Gaznabi Safwan, Abugroun Ashraf, Mahbub Hasan, Campos Enrique
Department of Internal Medicine, Advocate Illinois Masonic Medical Center, 836 W Wellington Ave., Chicago, IL 60657, USA.
Department of Internal Medicine, Flushing Hospital Medical Center, 4500 Parsons Blvd, Flushing, NY 11355, USA.
Case Rep Cardiol. 2019 Apr 9;2019:6076923. doi: 10.1155/2019/6076923. eCollection 2019.
A 79-year-old male was admitted to the hospital for acute exacerbation of heart failure. The patient had history of atrial fibrillation and was planned for cardioversion. Preprocedure transesophageal echocardiogram (TEE) revealed a large multilobulated mobile thrombus in the left atrial appendage. The patient refused warfarin therapy and instead chose to take rivaroxaban. Upon outpatient follow-up, 3 months later, no visible thrombus was appreciated on repeat TEE. This case demonstrates successful resolution of left atrial and left atrial appendage thrombi with the use of rivaroxaban. At present time, limited data is available to support the use of rivaroxaban for treatment of intracardiac thrombi. This case highlights the need for further studies to investigate the outcomes and relative efficiency of use of direct oral anticoagulants (DOACs) in lysis of intracardiac thrombus. The benefits of DOACs compared to the standard of therapy could increase patient compliance, reduce length of stay, and improve treatment efficacy.
一名79岁男性因心力衰竭急性加重入院。该患者有房颤病史,计划进行心脏复律。术前经食管超声心动图(TEE)显示左心耳内有一个大的多叶状活动血栓。患者拒绝华法林治疗,而是选择服用利伐沙班。3个月后的门诊随访中,复查TEE未发现可见血栓。该病例表明使用利伐沙班成功消除了左心房和左心耳血栓。目前,支持使用利伐沙班治疗心内血栓的数据有限。该病例凸显了进一步研究以调查直接口服抗凝剂(DOACs)在心内血栓溶解中的疗效和相对有效性的必要性。与标准治疗相比,DOACs的益处可能会提高患者依从性、缩短住院时间并提高治疗效果。